Orphan Nuclear Receptors as Targets for Drug Development

被引:29
|
作者
Mukherjee, Subhajit [1 ]
Mani, Sridhar [1 ]
机构
[1] Albert Einstein Coll Med, Genet & Canc Ctr, Dept Med, Bronx, NY 10461 USA
关键词
agonist; antagonist; ligand binding domain; orphan nuclear receptor; PREGNANE-X-RECEPTOR; LIGAND-BINDING DOMAIN; CONSTITUTIVE ANDROSTANE RECEPTOR; STEROIDOGENIC FACTOR-I; ESTROGEN-RELATED RECEPTOR; HETERODIMER PARTNER GENE; INDEPENDENT TRANSCRIPTIONAL ACTIVATION; ADRENAL HYPOPLASIA CONGENITA; NEGATIVE FEEDBACK-REGULATION; RESPONSIVE ENHANCER MODULE;
D O I
10.1007/s11095-010-0117-7
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Orphan nuclear receptors regulate diverse biological processes. These important molecules are ligand-activated transcription factors that act as natural sensors for a wide range of steroid hormones and xenobiotic ligands. Because of their importance in regulating various novel signaling pathways, recent research has focused on identifying xenobiotics targeting these receptors for the treatment of multiple human diseases. In this review, we will highlight these receptors in several physiologic and pathophysiologic actions and demonstrate how their functions can be exploited for the successful development of newer drugs.
引用
收藏
页码:1439 / 1468
页数:30
相关论文
共 50 条